Aclaris Therapeutics Inc (ACRS)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 7.75M | 2.53M | 1.87M | 9.28M | 17.57M | 2.4M | 2.77M | 4.35M |
Operating Income | -21.98M | -30.72M | -33.32M | -29.88M | -30.35M | -16.13M | -12.66M | -9.67M |
Pre Tax Income | -27.64M | -28.16M | -29.57M | -29.26M | -1.86M | -16.94M | -10.99M | -7.59M |
Net Income | -27.64M | -28.16M | -29.57M | -29.26M | -1.49M | -16.94M | -10.99M | -7.59M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -20.54M | -28.96M | -31.07M | -27.56M | -28.16M | -14.14M | -10.79M | -12.64M |
EBITDA | -21.79M | -30.52M | -33.1M | -29.66M | -23.49M | -15.89M | -12.41M | -9.49M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 1.68M | 10.09M | 4.23M | 6.48M | 6.76M | 29.75M | 31.25M |
Operating Income | -48.57M | -72.42M | -135.41M | -111.06M | -50.91M | -65.38M | -85.15M | -124.26M |
Pre Tax Income | -48.08M | -70.35M | -132.74M | -113.54M | -51.34M | -90.87M | -86.91M | -88.85M |
Net Income | -48.08M | -68.52M | -132.74M | -161.35M | -51.02M | -90.87M | -86.91M | -88.48M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.845 | -2.221 | -3.221 | -3.889 | -1.131 | -1.484 | -1.303 | -1.249 |
EBIT | -48.08M | -70.35M | -132.74M | -113.54M | -51.34M | -66.53M | -82.21M | -115.75M |
EBITDA | -48.45M | -72.02M | -133.54M | -90.97M | -49.59M | -64.46M | -84.36M | -116.77M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.